header logo image


Page 25«..1020..24252627..3040..»

Archive for the ‘Biotechnology’ Category

PDS Biotechnology Corporation (PDSB) and the Battle of Fundamental vs. Technical – The News Heater

Wednesday, July 8th, 2020

PDS Biotechnology Corporation (NASDAQ:PDSB) went up by 17.54% from its latest closing price when compared to the 1-year high value of $6.71 and move down -233.83%, while PDSB stocks collected -21.01% of loss with the last five trading sessions. Press Release reported 33 min ago that Thinking about buying stock in Annovis Bio, Corvus Pharmaceuticals, MGM Resorts, PDS Biotechnology, or Remark Holdings?

PDSB stocks went up by 5.56% for the week, with the monthly jump of 22.14% and a quarterly performance of 154.62%, while its annual performance rate touched -72.10%. The simple moving average for the period of the last 20 days is 30.50% for PDSB stocks with the simple moving average of -0.02% for the last 200 days.

Many brokerage firms have already submitted their reports for PDSB stocks, with Alliance Global Partners repeating the rating for PDSB shares by setting it to Buy. The predicted price for PDSB socks in the upcoming period according to Alliance Global Partners is $4 based on the research report published on May 27, 2020.

Noble Capital Markets, on the other hand, stated in their research note that they expect to see PDSB stock at the price of $5.45. The rating they have provided for PDSB stocks is Outperform according to the report published on March 9, 2020.

Chardan Capital Markets gave Buy rating to PDSB stocks, setting the target price at $10 in the report published on October 24, 2019.

After a stumble in the market that brought PDSB to its low price for the period of the last 52 weeks, PDS Biotechnology Corporation was unable to take a rebound, for now settling with -70.04% of loss for the given period.

The stock volatility was left at 16.75%, however, within the period of a single month, the volatility rate increased by 25.50%, while the shares surge at the distance of +37.84% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +116.19% upper at the present time.

In the course of the last 5 trading sessions, PDSB went down by -21.01%, which changed the moving average for the period of 200 days to the total of -64.03% of losses for the stock in comparison to the 20-day moving average settled at $1.5684. In addition, PDS Biotechnology Corporation saw -35.47% in overturn over the period of a single year with a tendency to cut further losses.

See more here:
PDS Biotechnology Corporation (PDSB) and the Battle of Fundamental vs. Technical - The News Heater

Read More...

Marine Biotechnology Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Wednesday, July 8th, 2020

New Jersey, United States,- Market Research Intellect sheds light on the market scope, potential, and performance perspective of the Global Marine Biotechnology Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the global Marine Biotechnology market.

The research study includes the latest updates about the COVID-19 impact on the Marine Biotechnology sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Marine Biotechnology manufacturers/companies operating at both regional and global levels:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=200617&utm_source=3WN&utm_medium=888

The Marine Biotechnology market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Marine Biotechnology market.

This study analyzes the growth of Marine Biotechnology based on the present, past and futuristic data and will render complete information about the Marine Biotechnology industry to the market-leading industry players that will guide the direction of the Marine Biotechnology market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Marine Biotechnology market. Additionally, it includes a share of each segment of the Marine Biotechnology market, giving methodical information about types and applications of the market.

Reasons for Buying Marine Biotechnology Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Marine Biotechnology market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=200617&utm_source=3WN&utm_medium=888

In the end, the Marine Biotechnology market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Marine Biotechnology market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Scintillator Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Smart Sensor Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Electric Vehicle Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Counterfeit Money Detection Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Distributed Temperature Sensing Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Excerpt from:
Marine Biotechnology Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read More...

PDS Biotechnology Corporation (PDSB) Quarterly Performance is 154.62%: Here is the Surprise Factor – The InvestChronicle

Wednesday, July 8th, 2020

For the readers interested in the stock health of PDS Biotechnology Corporation (PDSB). It is currently valued at $1.99. When the transactions were called off in the previous session, Stock hit the highs of $1.74, after setting-off with the price of $1.64. Companys stock value dipped to $1.62 during the trading on the day. When the trading was stopped its value was $1.71.

Recently in News on June 22, 2020, PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer. NCI-led Phase 2 clinical trial of this reported combination was initiated in June 2020. You can read further details here

PDS Biotechnology Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $3.1748 on 01/07/20, with the lowest value was $0.6153 for the same time period, recorded on 04/02/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, PDS Biotechnology Corporation shares are logging -70.34% during the 52-week period from high price, and 223.42% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $0.62 and $6.71.

The companys shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5583148 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the PDS Biotechnology Corporation (PDSB) recorded performance in the market was -35.47%, having the revenues showcasing 154.62% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 27.04M, as it employees total of 16 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.1152, with a change in the price was noted +0.7400. In a similar fashion, PDS Biotechnology Corporation posted a movement of +56.06% for the period of last 100 days, recording 1,083,296 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity The total Debt to Equity ratio for PDSB is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Raw Stochastic average of PDS Biotechnology Corporation in the period of last 50 days is set at 53.42%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 46.30%. In the last 20 days, the companys Stochastic %K was 34.15% and its Stochastic %D was recorded 29.94%.

Considering, the past performance of PDS Biotechnology Corporation, multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -35.47%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -32.41%, alongside a downfall of -72.10% for the period of the last 12 months. The shares increased approximately by 5.56% in the 7-day charts and went down by 22.14% in the period of the last 30 days. Common stock shares were driven by 154.62% during last recorded quarter.

See the original post here:
PDS Biotechnology Corporation (PDSB) Quarterly Performance is 154.62%: Here is the Surprise Factor - The InvestChronicle

Read More...

10 Best Biotechnology Degrees – College Choice

Monday, July 6th, 2020

Genetic engineering. Fermentation. Virology. Put on your safety goggles youre about to earn one of the best Biotechnology degrees in the nation.

Biotechnology is all about using biological systems plants, animals, genes, etc. to develop or design new products. This covers a lot of ground. You could use biotechnology in medicine, agriculture, food science, industrial materials the list could go on!

If you want to use science to fight diseases, solve hunger crises, and develop new biofuels, then a degree in Biotechnology is right up your alley.

The first step to a career in this area is a bachelors degree in either biology or biotechnology.

Youll find that biotechnology covers a lot of different areas. Most of these schools help guide you into a facet of biotechnology that best fits your interests and academic passions.

For example, do you want to get down to the nitty-gritty of the natural world? Check out the Microbial Biotechnology concentrations at UC Davis, Cal Poly Pomona, or SUNY College of Environmental Science and Forestry.

Do you like looking at the bigger picture? Then take a look at the Plant Biotechnology and Animal Biotechnology tracks at the University of Georgia and SUNY Cobleskill.

Regardless of which specific area of biotechnology you want to explore, all of these programs will give you a fantastic foundational understanding of the basics. If your schedule isnt quite going to line up with a full-time, on-campus program, check out College Choices list of the 50 Best Online Colleges and Universities.

Earning a degree in the world of biotechnology will guarantee you not only a rewarding career, but a financially secure future. You could take this degree in so many different areas, but three potential roles you could find yourself pursuing are a Microbiologist, a Biomedical Engineer, or a Biological Technician. All three of these jobs offer a comfortable annual salary:

These figures, of course, adjust depending on where you are working. For example, working in the pharmaceutical and medical world will earn you a higher salary than working at a private or state-level setting. According to the Bureau of Labor and Statistics, employment in biotechnology careers is expected to increase by over 10 percent in the next 10 years.

Biotechnology is a field with virtually no limits. You can take your degree and apply it to medicine, agriculture, transportation, and beyond. If youre more interested in the research side of things, you could work in a laboratory or a think-tank at a university.

If youre the kind of person who likes to get their hands dirty, you could cater your career to field experiments and trips around the world to test soil and plant samples. Here are just a few of the many careers you could pursue with a degree in biotechnology:

Since youre starting with a bachelors degree, your admissions requirements will look pretty similar to any other degree requirements. Youll take the SAT/ACT, write a few essays, turn in your transcripts, and hope for the best!

But here are a few things you can do to optimize your chances at getting into the best program possible:

Below youll find the 10 Best Biotechnology degrees. We took a number of steps to find our list. First, we gathered the academic quality of each program. Then we looked at affordability and the return on investment a big factor in how you decide on a school. Last but not least, we factored in student happiness using retention rates and graduation rates of each program.

Our methodology draws from our data team at College Choice, the quality resources at U.S. News & World Report, and the statistics at Payscale.com. Heal the world and feed the world with a degree in Biotechnology!

See our rankings methodology page.

Read the original post:
10 Best Biotechnology Degrees - College Choice

Read More...

Biotech – Engineering Biology to Service Us

Monday, July 6th, 2020

I recently got my proposal rejected by the SBIR program. What bothered me the most was that all three had failed to cite any fundamental issues with the scientific merit of the study. Their resins for rejection were as follows:

Proposed PI does not hit a Ph.D in the field for which he describes his research.

Lab facilities that had agreed to host the proposers research do not explicitly list the presence of electron microscopes

PI did not outline his strategy for addressing regulatory hurdles in bringing the proposed construct to market.

PI did not cite any prior, existing relationships with partners capable of navigating the regulatory space.

Project leans on two fashionable areas of research and fails to demonstrate significant market need.

PI cites click-chemistry as one of the methods employed in the research but lacks anyone on the project team with direct experience in said method.

It felt really discouraging to read through the reviewer opinions, because they attacked the project at at places that (in my opinion) dont have as much weight as the research itself. The hypothesis was built on a solid review of over 30 primary sources and the reviewers barely said anything about the actual science of it.

I guess Im not ready to bury this thing yet and wanted to know if there were other, international funding sources I could resubmit to.

Read the original:
Biotech - Engineering Biology to Service Us

Read More...

Biotechnology Algae Cultivation Process (Micro Algae) Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Monday, July 6th, 2020

New Jersey, United States,- Market Research Intellect sheds light on the market scope, potential, and performance perspective of the Global Biotechnology Algae Cultivation Process (Micro Algae) Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the global Biotechnology Algae Cultivation Process (Micro Algae) market.

The research study includes the latest updates about the COVID-19 impact on the Biotechnology Algae Cultivation Process (Micro Algae) sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Biotechnology Algae Cultivation Process (Micro Algae) manufacturers/companies operating at both regional and global levels:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=375531&utm_source=3WN&utm_medium=888

The Biotechnology Algae Cultivation Process (Micro Algae) market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Biotechnology Algae Cultivation Process (Micro Algae) market.

This study analyzes the growth of Biotechnology Algae Cultivation Process (Micro Algae) based on the present, past and futuristic data and will render complete information about the Biotechnology Algae Cultivation Process (Micro Algae) industry to the market-leading industry players that will guide the direction of the Biotechnology Algae Cultivation Process (Micro Algae) market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Biotechnology Algae Cultivation Process (Micro Algae) market. Additionally, it includes a share of each segment of the Biotechnology Algae Cultivation Process (Micro Algae) market, giving methodical information about types and applications of the market.

Reasons for Buying Biotechnology Algae Cultivation Process (Micro Algae) Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Biotechnology Algae Cultivation Process (Micro Algae) market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=375531&utm_source=3WN&utm_medium=888

In the end, the Biotechnology Algae Cultivation Process (Micro Algae) market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Biotechnology Algae Cultivation Process (Micro Algae) market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Body Wash and Shower Gel Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Blood Glucose Monitoring Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Bisoprolol Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Bitterness Suppressors and Flavor Carriers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Blood Collection, Processing, Management Devices and Consumables Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See original here:
Biotechnology Algae Cultivation Process (Micro Algae) Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read More...

Pharmaceutical and biotechnology Segment to be the Most Lucrative in Chromatography Systems Market – Jewish Life News

Monday, July 6th, 2020

There is an unexpected shift in the world, and many sectors are experiencing thoughts triggered by the COVID-19 pandemic. The outbreak of COVID-19 has had a positive impact on the demand for chromatography. In the pharmaceutical industry, chromatography technology is commonly used for the detection of cancer cells. It is also used for drinking water and air processing, plasma fractionation, enzyme purification, and purification. The Environmental Authority, for example, listed chromatography as safe for the measurement of drinking water purity as a means of easy propagation of the coronavirus through polluted water. During this coronavirus crisis, we are helping our clients in understanding the impact of COVID-19 on the chromatography system market.

Our report includes:

A new report by Research Dive states that the global chromatography system market is set to grow at a CAGR of 6.9% and is projected to garner a revenue of $16,304.0 million during the period of forecast from 2019 to 2026. The report delivers in-depth insights into opportunities, vital segments, restraints, drivers, and prominent players of the global market. Based on the type, end-use, and region of the global market segmentation. The report offers insights on drivers, opportunities, restraints, analysis of segment, and competitive market players. Increasing the use of chromatography methods in the pharmaceutical industry is a significant factor for market growth, according to our analysts. Nonetheless, due to the existence of capillaries for the oxygen, hydrogen, and methane separation, a requirement of qualified professionals and high construction costs and maintenance costs is anticipated to impede the growth of the market for the chromatography device. The global market is segmented on the basis of type, end-use industry, and region.

Check out How COVID-19 impact on the Chromatography Systems Market. Click here to Connect with Analyst @ https://www.researchdive.com/covid-19-insights/207/chromatography-system-market#myQueryForm

Pharmaceutical and biotechnology Segment to be the Most Lucrative

The chromatography device market is categorized on the basis of end-use application into hospitals and medical, pharmaceutical, and biotechnology industries and the food and agriculture industry. The demand for pharmaceuticals and biotechnology is projected to rise by 7.3% CAGR, with $5,651.4 million anticipated by 2026. The need for highly sensitive product information in terms of quality and purity, increased use of biopharmaceuticals, especially bio-similar medicines, and monoclonal antibodies that are expected to drive the need for chromatography system are all contributing to the size of the market in the prediction time frame.

The world market share for Asia-Pacific is prominent and is projected to hit $3,283.9 million by 2026 @ https://www.researchdive.com/covid-19-insights/207/chromatography-system-market

Asia-Pacific Region to Expand Business at a Considerable Growth Rate

The world market share for Asia-Pacific is prominent and is projected to hit $3,283.9 million by 2026. The rise in research activities in different fields, such asbiological innovation and pharmaceutical purpose, has contributed to this dominance. A substantial increase is expected to result in sales of $3,283.9 million by 2026, with a 7.5% CAGR in demand for Asia-Pacific RO water treatment system components. In Asia-Pacific, this anticipated rise is mainly due to the existence, of several biopharmaceutical research and development centres, in various major companies such as Merck, Eli Lilly, and Pfizers. These factors are anticipated to fuel the growth of the market over time.

Prominent Players of the Market

Some of the key players of the global chromatography system market include Agilent Technologies (NYSE: A), Perkin Elmer, APIX, Thermo Fisher Scientific Inc., Xylem (OI Analytical), CDS Analytical, Shimadzu Corporation, Waters Corporation, Jasco Inc, Bio-Rad Laboratories and others. These players are adopting several strategies such as mergers & acquisitions and novel product developments to improve their company position in the global industry.

About Us:Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact us:Mr. Abhishek PaliwalResearch Dive30 Wall St. 8th Floor, New YorkNY 10005 (P)+ 91 (788) 802-9103 (India)+1 (917) 444-1262 (US)Toll Free: +1-888-961-4454E-mail: [emailprotected]LinkedIn:https://www.linkedin.com/company/research-dive/Twitter:https://twitter.com/ResearchDiveFacebook:https://www.facebook.com/Research-Dive-1385542314927521Blog:https://www.researchdive.com/blogFollow us:https://marketinsightinformation.blogspot.com/

See original here:
Pharmaceutical and biotechnology Segment to be the Most Lucrative in Chromatography Systems Market - Jewish Life News

Read More...

Is Immunomedics, Inc. (IMMU) a Winner in the Biotechnology Industry? – InvestorsObserver

Monday, July 6th, 2020

A rating of 80 puts Immunomedics, Inc. (IMMU) near the top of the Biotechnology industry according to InvestorsObserver. Immunomedics, Inc.'s score of 80 means it scores higher than 80% of stocks in the industry. Immunomedics, Inc. also received an overall rating of 70, putting it above 70% of all stocks. Biotechnology is ranked 13 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 70 would rank higher than 70 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Immunomedics, Inc. (IMMU) stock is trading at $41.15 as of 1:12 PM on Monday, Jul 6, an increase of $3.61, or 9.62% from the previous closing price of $37.54. The stock has traded between $39.22 and $41.40 so far today. Volume today is 3,753,250 compared to average volume of 3,897,633.

To see the top 5 stocks in Biotechnology click here.

Read the original post:
Is Immunomedics, Inc. (IMMU) a Winner in the Biotechnology Industry? - InvestorsObserver

Read More...

Clinical Decision Support Systems (CDSS) Market Application Products, Applications with Biotechnology and Nature Research Report 2020 – Owned

Monday, July 6th, 2020

Clinical Decision Support Systems (CDSS) Market Trends By Component (Software), Product (Integrated CDSS), Model (Knowledge-Based CDSS) Delivery Mode (On-Premise CDSS), Mode of Advice (Active CDSS), Setting (Inpatient Setting), Type (Therapeutic CDSS), Application (Advanced CDSS), Growth Opportunity, Size, Demand, Technology and Regional Analysis Global Forecast Till 2023.

The Clinical Decision Support Systems (CDSS) Market Size is set to witness a CAGR of 12%, which projects above-average growth for the global market.

The Clinical Decision Support Systems (CDSS) market is growing significantly over the past few years. The healthcare industry is witnessing a spurting growing due to the ever-increasing population that is prompting the need for effective treatment and care. The Players that leads the global CDSS market include

Request for a FREE [emailprotected]https://www.marketresearchfuture.com/sample_request/6038

By Latest Product launches and investment in R&D are a few of the important strategies employed by the top players in the global market to facilitate growth.

Prominent players analyzed in the report include

Allscripts

Carestream

Agfa-Gevaert Group

Elsevier B.V.

Athenahealth

Hearst Health

Cerner Corporation

Meditech

and Epic Systems Corporation

Wolters Kluwer Health

and among others.

Clinical Decision Support Systems (CDSS) Market Segmentation:

The global CDSS market is segmented into component, product, model, delivery mode, mode of advice, settings, type, application, and region. By component, the market is segmented into services, software, and hardware. Software accounted for the largest share of the market and valued USD 493.43 million in 2017 and is expected to maintain its lead while reaching an evaluation of USD 982.42 million by the end of 2023.

By product, the market is segmented into integrated CDSS and standalone CDSS. Integrated CDSS is found to have the majority share and is expected to grow at the fastest CAGR. Integration allows healthcare professionals to access solutions that are interconnected and share a common user interface and database, thus simplifying the process.

By model, the market is segmented into Knowledge-based CDSS, and Non-Knowledge-based CDSS. Knowledge-based CDSS accounts for the majority share of the market due to the high number of advantages this system has over non-knowledge based CDSS.

By delivery mode, the market is segmented into in-premise and cloud-based systems. With global technology moving toward adoption of cloud-based systems, the healthcare sector is no different. The low capital and operational costs incurred in the implementation of cloud-based systems is highly beneficial as compared to on-premise systems.

By mode of advice, the market is segmented into passive CDSS and active CDSS. The active CDSS segment accounts for the largest share of the market with approximately 75% of the total share.

By settings, the market is segmented into inpatient settings and ambulatory care settings. Inpatient settings account for over 70% of the total market due to the requirement of a large volume of patient data that is captured and analyzed by healthcare professionals.

By type, the market is segmented into therapeutic clinical decision support system and diagnostic clinical decision support system. Due to its ability to transform clinical health practices by providing a user interface with the best therapeutic practices, the therapeutic CDSS segment has the leading market position.

By application, the market is segmented into conventional clinical support systems and advanced clinical decision support system. The advanced CDSS segment accounts for the largest segment with the highest CAGR of 12.34% during the assessment period. Users of CDSS has opting to upgrade conventional systems to include premium functions such as treatment planning protocol, population health management, patient record management, protocol validation, reasoning based models and health economics management too.

Browse Complete Premium Report [emailprotected]https://www.marketresearchfuture.com/reports/clinical-decision-support-systems-market-6038

18 LIST OF TABLES

TABLE 1 PRIMARY INTERVIEWS

TABLE 2 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20152023 (USD MILLION)

TABLE 3 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY REGION, 20152023 (USD MILLION)

TABLE 4 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY REGION, 20152023 (USD MILLION)

TABLE 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY REGION, 20152023 (USD MILLION)

TABLE 6 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20152023 (USD MILLION)

TABLE 7 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INTEGRATED CDSS, BY REGION, 20152023 (USD MILLION)

TABLE 8 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR STANDALONE CDSS, BY REGION, 20152023 (USD MILLION)

TABLE 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20152023 (USD MILLION)

TABLE 10 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR KNOWLEDGE-BASED CDSS, BY REGION, 20152023 (USD MILLION)

TABLE 11 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR NON-KNOWLEDGE-BASED CDSS, BY REGION, 20152023 (USD MILLION)

Continued

Contact:

Market Research Future, Pune 411028

Maharashtra, India

+1 646 845 9312

Email:[emailprotected]

See the original post here:
Clinical Decision Support Systems (CDSS) Market Application Products, Applications with Biotechnology and Nature Research Report 2020 - Owned

Read More...

2020 Impact of COVID-19 on Food Biotechnology Size, Share, Growth, Demand and Forecast to 2026 – Owned

Monday, July 6th, 2020

It is our aim to provide our readers with report for Food Biotechnology Market, which examines the industry during the period 2020 2026. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the Food Biotechnology Market report. Next, the document will study the factors responsible for hindering and enhancing growth in the industry. After covering various areas of interest in the industry, the report aims to provide how the Food Biotechnology Market will grow during the forecast period.

The major vendors covered:

ArcadiaBiosciences, AquaBountyTechnologies, BASFPlantScience, Bayer CropScienceAG, Camson Bio Technologies, DowDuPont, EvogeneLtd, Hy-LineInternational, KWS Group, Monsanto, Origin Agritech, Syngenta AG, etc and more

The final report will add the analysis of the Impact of Covid-19 on Food Biotechnology Market.

Request a free sample copy @ https://www.reportsandmarkets.com/sample-request/global-food-biotechnology-market-size-status-and-forecast-2018-2025?utm_source=primefeed&utm_medium=38

The Food Biotechnology Market report between the years 2020 2026 will highlight the current value of the industry. At the same time, there is also an estimate of how much this line of business will be worth at the end of the forecast period. As it is our goal to maintain high levels of accuracy at all times, we will take a look at the CAGR of the Food Biotechnology Market. We make sure that all the information available in this report has excellent levels of readability. One way we achieve this target is by Food Biotechnology Market segmentation. Going through the report for 2020 2026 will bring our readers up-to-date regarding this industry.

While examining the information from this document, one thing becomes clear, the elements which contribute to increase in demand for the product or service. At the same time, there will be a focus on what drives the popularity of these types of products or services. This report is for those who want to learn about Food Biotechnology Market, along with its forecast for 2020 2026. Information regarding market revenue, competitive partners, and key players will also be available.

Segmentation

As discussed earlier, there is segmentation in the Food Biotechnology Market report, to improve the accuracy and make it easier to collect data. The categories which are the dividing factors in the industry are distribution channels, application, and product or service type. With this level of segmentation, it becomes easier to analyze and understand the Food Biotechnology Market. At the same time, there is emphasis on which type of consumers become the customers in this industry. When it comes to distribution channels, the Food Biotechnology Market report looks at the different techniques of circulation of the product or service.

Regional Overview

In this part of the Food Biotechnology Market report, we will be taking a look at the geographical areas and the role they play in contributing to the growth of this line of business. The areas of interest in this document are as follows Middle East and Africa, South and North America, Europe, and Asia Pacific. From the Food Biotechnology Market report, it becomes clear which region is the largest contributor.

Latest Industry News

From this Food Biotechnology Market report, the reader will also get to learn about the latest developments in the industry. The reason is that these products or services have the potential to disrupt this line of business. If there is information about company acquisitions or mergers, this information will also be available in this portion of the Food Biotechnology Market report.

If you have any special requirements about this Food Biotechnology Market report, please let us know and we can provide custom report.

Inquire more about this report @ https://www.reportsandmarkets.com/enquiry/global-food-biotechnology-market-size-status-and-forecast-2018-2025?utm_source=primefeed&utm_medium=38

About Us

ReportsAndMarkets.com allocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serve our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Contact Us

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

View post:
2020 Impact of COVID-19 on Food Biotechnology Size, Share, Growth, Demand and Forecast to 2026 - Owned

Read More...

Food Biotechnology Market Expected to Witness the Highest Growth 2024 – News.MarketSizeForecasters.com

Monday, July 6th, 2020

Recently, Market Study Report, LLC, added a research on the ' Food Biotechnology market' which encompasses significant inputs with respect to market share, market size, regional landscape, contributing players, and revenue projection of this industry vertical. The report also educates investors regarding the existing tends, prime challenges, and current expansion strategies applied by the key organizations that constitute the hyperactive competitive gamut of this business sphere.

The Food Biotechnology market study report is a detailed analysis of this industry that is evaluated from the perspective of two major parameters - production and consumption. The report, with respect to the production aspect, encompasses details about the manufacturing of the product, its revenue, as well as the gross margins of the manufacturers renowned in the production of the same. The unit costs offered by the producers spanning various geographies between a stipulated timespan are also provided.

Request a sample Report of Food Biotechnology Market at:https://www.marketstudyreport.com/request-a-sample/2524960?utm_source=marketsizeforecasters.com&utm_medium=Ram

Additionally, the study includes information about the consumption aspect. In terms of consumption, details about the product consumption value and product consumption volume are provided. The individual sale price alongside the status of the import and export graphs across various regions have also been provided. In addition, a detailed prediction pertaining to the production and consumption patterns over the forthcoming period has been given.

An overview of the regional landscape:

An outline of the product spectrum:

A gist of the application terrain:

Ask for Discount on Food Biotechnology Market Report at:https://www.marketstudyreport.com/check-for-discount/2524960?utm_source=marketsizeforecasters.com&utm_medium=Ram

An insight into the competitive reach:

The Food Biotechnology market report, in a nutshell, has been broken down into various parts, one of which comprises the basic industry definitions. The analysis on upstream raw materials, downstream consumer base, and equipment has also been carried out and has been duly presented in the report. Additionally, the development trends characterizing this industry in tandem with the marketing channels deployed by the manufacturers have been evaluated and provided suitably.

The Food Biotechnology market research report also plays host to information pertaining to the assessment of the feasibility of new investment projects. The research conclusions inferred from these studies are also accurately presented in the study.

For More Details On this Report: https://www.marketstudyreport.com/reports/global-food-biotechnology-market-professional-survey-2019-by-manufacturers-regions-types-and-applications-forecast-to-2024

Related Reports:

2. Global Electronic Alarm Clock Market Research Report 2019, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026Read More: https://www.marketstudyreport.com/reports/global-electronic-alarm-clock-market-research-report-2019-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

Read More Reports On: https://www.marketwatch.com/press-release/electric-heater-market-outlook-recent-trends-and-growth-forecast-2020-2025-2020-07-02?tesla=y

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

View post:
Food Biotechnology Market Expected to Witness the Highest Growth 2024 - News.MarketSizeForecasters.com

Read More...

Is Entasis Therapeutics Holdings Inc (ETTX) Stock Near the Top of the Biotechnology Industry? – InvestorsObserver

Monday, July 6th, 2020

Entasis Therapeutics Holdings Inc (ETTX) is near the bottom in its industry group according to InvestorsObserver. ETTX gets an overall rating of 38. That means it scores higher than 38 percent of stocks. Entasis Therapeutics Holdings Inc gets a 22 rank in the Biotechnology industry. Biotechnology is number 13 out of 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Entasis Therapeutics Holdings Inc (ETTX) stock is lower by -1.71% while the S&P 500 is unchanged 0% as of 9:53 AM on Monday, Jul 6. ETTX is down -$0.05 from the previous closing price of $2.92 on volume of 164,279 shares. Over the past year the S&P 500 has risen 5.18% while ETTX is down -54.80%. ETTX lost -$3.49 per share the over the last 12 months.

To screen for more stocks like ETTX click here.

See more here:
Is Entasis Therapeutics Holdings Inc (ETTX) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Read More...

Global Agriculture Biotechnology Market Expected to Reach Highest CAGR by 2025 Top Players- : ADAMA Agricultural Solutions, Vilmorin, Bayer,…

Monday, July 6th, 2020

This report on Global Agriculture Biotechnology Market is based on the in-depth view of Agriculture Biotechnology industry on the basis of market growth, market size, development plans and opportunities offered by the global Agriculture Biotechnology market. The report on Agriculture Biotechnology, gives an in-depth analysis of Agriculture Biotechnology market based on aspects that are very important for the market study. Factors like production, market share, revenue rate, regions and key players define a market study start to end. The energetic aspects studied in this report includes SWOT analysis, feasibility and forecast information. For the consumers to gain the in-depth analysis of the global keyword market and further growth of the market, the report offers significant statistics and information. Agriculture Biotechnology report studies the current state of the market to analyze the future opportunities and risks.

This study covers following key players:ADAMA Agricultural SolutionsVilmorinBayerBiocentury TransgeneCertisDow AgroSciencesEurofinsEvogeneGlobal Bio-chem TechnologySyngentaKWS SaatMarina BiotechMonsanto

Request a sample of this report @ https://www.orbismarketreports.com/sample-request/58818?utm_source=Puja

Primarily, the report delivers Agriculture Biotechnology introduction, overview, market objectives, market definition, scope, and market size valuation. Moreover, the report provides historical information with future forecast over the forecast period. Some of the important aspects analyzed in the report includes market share, production, key regions, revenue rate as well as key players. The Agriculture Biotechnology market has its impact all over the globe. On global level Agriculture Biotechnology industry is segmented on the basis of product type, applications, and regions. It also focusses on market dynamics, Agriculture Biotechnology growth drivers, developing market segments and the market growth curve is offered based on past, present and future market data. The industry plans, news, and policies are presented at a global and regional level.

Access Complete Report @ https://www.orbismarketreports.com/global-agriculture-biotechnology-market-size-status-and-forecast-2019-2025?utm_source=Puja

Market segment by Type, the product can be split into BiochipsDeoxy ribonucleic acid (DNS) sequencingGenome editing toolsRibonucleic acid interference (RNAI)Synthetic biology

Market segment by Application, split into Transgenic crops marketSynthetic biology-enabled products market

This Agriculture Biotechnology report also provides the readers with detailed figures at which the Agriculture Biotechnology market was valued in the historical year and its expected growth in upcoming years. Besides, analysis also forecasts the CAGR at which the Agriculture Biotechnology is expected to mount and major factors driving markets growth. The study on global Agriculture Biotechnology market, offers deep insights about the Agriculture Biotechnology market covering all the crucial aspects of the market.In addition, the report include deep dive analysis of the market, which is one of the most important features of the market. Furthermore, the need for making an impact is likely to boost the demand for the experts which are working in the market. Moreover, an in depth analysis of the competitors is also done to have an estimate for the market.

Some Major TOC Points:1 Report Overview2 Global Growth Trends3 Market Share by Key Players4 Breakdown Data by Type and ApplicationContinued

The Agriculture Biotechnology research study is a helpful analysis which emphasizing on geographical analysis, primary & secondary research methodologies, market drivers, and leading segmentation and sub-segments analysis. With the whole overview of the Agriculture Biotechnology market, the studyprovides the overall viability of future projects and delivers the Agriculture Biotechnology report conclusion. The Agriculture Biotechnology market report also delivers market evaluationalong with the PESTEL, SWOT, and other necessary data. In addition, the Agriculture Biotechnology market study categorizes the global market data by using numerous factors such as application, region, manufacturers, and type.

For Enquiry before buying report @ https://www.orbismarketreports.com/enquiry-before-buying/58818?utm_source=Puja

About Us : With unfailing market gauging skills, has been excelling in curating tailored business intelligence data across industry verticals. Constantly thriving to expand our skill development, our strength lies in dedicated intellectuals with dynamic problem solving intent, ever willing to mold boundaries to scale heights in market interpretation.

Contact Us : Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Here is the original post:
Global Agriculture Biotechnology Market Expected to Reach Highest CAGR by 2025 Top Players- : ADAMA Agricultural Solutions, Vilmorin, Bayer,...

Read More...

Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results – BioSpace

Monday, July 6th, 2020

SOUTH SAN FRANCISCO, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced thatit will report second quarter 2020 financial results on Thursday, August 6, 2020, after the close of the market.

Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host a conference call and webcast at 2:00 p.m. PT, 5:00 p.m. ET, on August 6, 2020, to discuss second quarter 2020 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call.

Individuals interested in listening to the conference call may do so by dialing:

US domestic callers: (877) 556-5248Outside US callers: (720) 545-0029Please reference Conference ID: 2068836

A live webcast of the conference call will be available online from the Investor Relations page of the Companys website at Events & Presentations. The link will not be active until 1:45 p.m. PT, 4:45 p.m. ET, on August 6, 2020.

After the live webcast, the call will be archived on Fluidigms Investor Relations page at investors.fluidigm.com. In addition, a telephone replay of the teleconference will be available approximately 90 minutes after the end of the call.

The replay dial-in numbers are:

US domestic callers: (855) 859-2056Outside US: (404) 537-3406Please reference Conference ID: 2068836

The telephone replay will be available until August 13.

About FluidigmFluidigm(Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, and plant and animal research laboratories worldwide. Together with them, we strive to increase the quality of life for all. For more information, visitfluidigm.com.

Fluidigm, theFluidigmlogo, and CyTOF are trademarks and/or registered trademarks ofFluidigm Corporationinthe United Statesand/or other countries. All other trademarks are the sole property of their respective owners. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

Available InformationWe use our website (fluidigm.com), investor site (investors.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm), and LinkedIn page (linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases,SECfilings, public conference calls, and webcasts.

Contact:

Agnes LeeVice President, Investor Relations650 416 7423agnes.lee@fluidigm.com

View post:
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results - BioSpace

Read More...

Cell Expansion Market Worth $30.1 billion by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

Monday, July 6th, 2020

CHICAGO, July 6, 2020 /PRNewswire/ -- According to the new market research report "Cell Expansion Marketby Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025", published by MarketsandMarkets,the Cell Expansion Marketis estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

Growth in this market is primarily driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.

The media segment accounted for the largest share of the consumables segment in the Cell Expansion Market

Based on product type, consumables are segmented into media, reagents, sera, and disposables. The media segment accounted for the largest share of the consumables segment in the market. The large share of this segment can be attributed to its high requirement during the production of pharmaceutical products and rising R&D investments on cell-based therapies.

Browsein-depth TOC on"Cell Expansion Market"

595 Tables 33 Figures354 Pages

Biotechnology & biopharmaceutical companies accounted for the fastest-growing end user segment of the market

Based on end-users, the market has been segmented into research institutes, biotechnology & biopharmaceutical companies, cell banks, and other end users (includes hospitals, diagnostic centers, and laboratories). In 2019, biotechnology & biopharmaceutical companies were the largest end-users in the Cell Expansion Market, and the trend is the same throughout the forecast period. Increasing production of regenerative medicine and rising awareness regarding advanced treatment methods such as personalized medicines and other cell-based therapies are the major driving factors for this segment.

North America accounted for the largest share of the market

North America accounted for the largest share of the market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, increasing geriatric population, and the strong presence of industry players in the region.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883

Some of the leading players in the Cell Expansion Market include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany)

Browse Adjacent Markets:Biotechnology Market Research Reports & Consulting

Get Special Pricing on Bundle Reports:

https://www.marketsandmarkets.com/RequestBundleReport.asp?id=194978883

Browse Related Reports:

Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/cell-isolation-market-103931479.html

3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected] Visit Our Website: https://www.marketsandmarkets.comResearch Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-expansion-market.aspContent Source: https://www.marketsandmarkets.com/PressReleases/cell-expansion.asp

SOURCE MarketsandMarkets

Go here to see the original:
Cell Expansion Market Worth $30.1 billion by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire

Read More...

White Biotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2025 – Daily Research Chronicles

Monday, July 6th, 2020

The White Biotechnology Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the White Biotechnology market report provides authentic and reliable estimates for the forecast period. The Best part of this report is, this analyses the current state where all are fighting with the COVID-19, The report also provides the market impact and new opportunities created due to the Covid19 catastrophe.

Leading Companies Reviewed in the Report are:

Solazyme Inc., Novozymes, Global Bioenergies, Amyris, BioAmber, Metabolic Explorer, Deinove, Evolva, Fermentlag, Codexis and many more

Get Exclusive Sample of Report on White Biotechnology market is available @ https://www.adroitmarketresearch.com/contacts/request-sample/117

The prime objective of this report is to help the user to gain a complete knowledge of the market in terms of its definition, segmentation, influential trends, market potential, and the challenges that the market is facing. The White Biotechnology Market report offers recorded market information from 2015 to 2019, reveals revenue estimations for 2020 and figures from 2020 till 2025

White Biotechnology Market highlights industry essentials, regional market, global economic industry growth, and market competitors along with their market share. White Biotechnology Market report is concluded through collecting the number of researches. Sever industry based analytical techniques were also analyzed for a better understanding of this market.

Quick Read Table of Contents of this Report @ https://www.adroitmarketresearch.com/industry-reports/white-biotechnology-market

White Biotechnology market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

In addition, the number of business tactics aids the White Biotechnology market players to give competition to the other players in the market while recognizing the significant growth prospects. Likewise, the research report includes significant information regarding the market segmentation which is designed by primary and secondary research techniques. It also offers a complete data analysis about the current trends which have developed and are expected to become one of the strongest White Biotechnology market forces into coming future. In addition to this, the White Biotechnology report provides the extensive analysis of the market restraints that are responsible for hampering the White Biotechnology market growth along with the report also offers a comprehensive description of each and every aspects and its influence on the keyword market.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/117

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX 75204, U.S.APhone No.: USA: +1 972-362 -8199 / +91 9665341414

Read more here:
White Biotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2025 - Daily Research Chronicles

Read More...

Blue Biotechnology Market Growth By Manufacturers, Type And Application, Forecast To 2026 – 3rd Watch News

Monday, July 6th, 2020

New Jersey, United States,- Market Research Intellect sheds light on the market scope, potential, and performance perspective of the Global Blue Biotechnology Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the global Blue Biotechnology market.

The research study includes the latest updates about the COVID-19 impact on the Blue Biotechnology sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Blue Biotechnology manufacturers/companies operating at both regional and global levels:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=375159&utm_source=3WN&utm_medium=888

The Blue Biotechnology market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Blue Biotechnology market.

This study analyzes the growth of Blue Biotechnology based on the present, past and futuristic data and will render complete information about the Blue Biotechnology industry to the market-leading industry players that will guide the direction of the Blue Biotechnology market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Blue Biotechnology market. Additionally, it includes a share of each segment of the Blue Biotechnology market, giving methodical information about types and applications of the market.

Reasons for Buying Blue Biotechnology Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Blue Biotechnology market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=375159&utm_source=3WN&utm_medium=888

In the end, the Blue Biotechnology market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the global Blue Biotechnology market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Industrial Networking Solutions Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Location-Based Services (LBS) And Real-Time Location Systems (RTLS) Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Middle East & Africa Cloud Infrastructure Services Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Middle East & Africa Cybersecurity Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Point-Of-Care Diagnostics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Read more here:
Blue Biotechnology Market Growth By Manufacturers, Type And Application, Forecast To 2026 - 3rd Watch News

Read More...

The Largest Biotech Companies In The World – WorldAtlas

Friday, July 3rd, 2020

By Amber Pariona on April 25 2017 in Economics

Biotechnology is the use of advances in life sciences in the production of marketable goods. A biotech company, therefore, is an enterprise that produces products and services by utilizing biotechnology. Many biotech companies exist around the world. This article takes a look at some of the largest biotech companies according to market capitalization values.

The largest biotech company in the world is Johnson & Johnson, founded in 1885 as a provider of ready-to-use surgical dressings. Today, this company is a multinational pharmaceutical, medical devices, and first aid supplies manufacturer. Some of the most well known Johnson & Johnson brands include: Tylenol, Neutrogena, Band-Aid, Acuvue contact lenses, and Clear and Clear. It operates in 60 countries with sales in more than 175 countries and headquarters in New Brunswick in the US state of New Jersey. It employs approximately 127,100 individuals and had global sales of around $70.1 billion in 2015. In 2016, Johnson & Johnson had a market capitalization of $314.1 billion.

Pfizer is the second largest biotech company in the world. It was founded in 1849 as a chemicals company and began to grow significantly in the 1880s after producing and selling citric acid. Today, Pfizer is a global pharmaceutical company that specializes in vaccines and medicines for a wide range of health fields, including: oncology, immunology, diabetology, neurology, and cardiology. Some of its most well known brands areCelebrex, and Lipitor. Its corporate headquarters are in New York City, with research headquarters in Groton in the US state of Connecticut. This company has approximately 78,300 employees and had a 2015 revenue rate of $48.85 billion. In 2016, Pfizer had a market capitalization of $196.3 billion.

The third largest biotech company in the world is Roche, founded in 1896 as a provider of vitamins. It was the first company in the world to mass-produce synthetic vitamin C. Today, it is a multinational pharmaceuticals and diagnostics healthcare company. Some of the most well-known Roche products include: Valium, Bactrim, Avastin, and Naprosyn. Its headquarters are located in the city of Basel in Switzerland. Over the years, Roche has acquired a number of biotechnology companies with the most recent being Tensha Therapeutics for $115 million, announced in January of 2016. This company has around 88,509 employees and a 2014 revenue rate of $47.65 billion. In 2016, Roche had a market capitalization of $192.1 billion.

Novartis is the fourth largest biotech company in the world. It was founded in 1996 after a merger between Ciba-Geigy and Sandoz Laboratories. It is a multinational pharmaceutical company with headquarters in Basel, Switzerland that produces a number of drugs, consumer health products, and animal health products (for pets and livestock). Some of its most well-known pharmaceuticals include: Diclofenac, Clozapine, Letrozole, and Ciclosporin. Novartis is a member of the International Federation of Pharmaceutical Manufacturers and Associations, the Pharmaceutical Research and Manufacturers of America, and the European Federation of Pharmaceutical Industries and Associations. This company employs 118,700 individuals around the world and in 2015, had a revenue of $50.359. In 2016, Novartis had a market capitalization of $170.5 billion.

The chart published below provides a more complete list of the largest biotech companies in the world.

See more here:
The Largest Biotech Companies In The World - WorldAtlas

Read More...

Importance Of Biotechnology | My Essay Point

Friday, July 3rd, 2020

Biotechnology is a technology based on biology. This article talks about the importance of biotechnology in our lives.

The world we have live has been suffering for so long and humanity is facing an enormous problem on the excessive usage of natural resources. The energy we have been purging from these resources is diminishing and is now critically endangered for future use. Not only that but sudden changes to our environment brought tragedies and disaster that leaves mark for a lifetime. People has intelligently abuse our nature.

Its strange to know that most of the educated people regardless of gender are unaware of the importance of biotechnology in any aspects of our society, even though it is crystal clear that its technological value has foreseen for a long time to motivate the upcoming generations. It is certain that human existence and survival on the coming days rest on the development and rapidly advancement of biotechnology.

Because of the advancement of thorough researched and development, the importance of biotechnology has come to existence. It is a field in biology that is extensively used in engineering, medicine, science and technology, agriculture and other valuable form of applications. Biotechnology can be a great solution to mankind struggles. So, what does its all about? Briefly, it is merely an applied principles of chemistry, physics and engineering comprise into biological structure.

Application in modern era includes the field of genetic engineering. It is the usage of this technology to culture cells and tissues for the modification living organism for human purposes. By this, the importance of biotechnology in agriculture increases the crop production which makes it double or even higher than normal harvest. It has the ability to give biological protection from disease and pests, so a minor necessity for chemical insecticides. Biotechnology is capable of conveying genetic qualities of the crops that can withstand the changing climate condition, obtain an increase of nutritional qualities. This will provide the farmers a healthy lifestyle due to the less exposure of chemical residues and eventually give a higher profit.

Benefits of biotechnology can also be experienced in the medical institution. Its technological application includes pharmaceutical products and medicines, and human therapy. It helps produced large quantity of protein for nutritional supplements and insulin for diabetic patient treatment. The gene therapy, in which is the most successful result of biotechnology research use to cure aids and cancer.

Application on biotechnology can be seen in industrial plant and factories. They are used to give an improved effectiveness and competence in production process while reducing the impact to the environmental issues. Waste products can be treated and recycled as a help to preserve natural resources.

It is beyond expectation on what the biotechnology has accomplished and reached in just a matter of time. Humanity has just start to comprehend and recognized the endless opportunities it has open. As technology assures to provide solution to every frightening problem we face every now and then, so is mankind is expecting a more develop biotechnology in the future. A technology that is more reliable and firm. This is the importance of biotechnology; revolution of the future technology.

Do share your thoughts on Importance of Biotechnology in the comments below.

More here:
Importance Of Biotechnology | My Essay Point

Read More...

Biotechnology, B.S. & Penn State

Friday, July 3rd, 2020

Program Description

Biotechnology may be broadly defined as the application of principles of molecular and cell science in the production of biologically important or industrially useful products. Therefore, students in the Biotechnology major will

One very important strength of this major is the extensive laboratory experience each student receives. In the General option, students are very strongly encouraged to consider Cooperative Education with industry as an integral part of their curriculum. In addition to the General option in Biotechnology, the major also offers the Clinical Laboratory Science option.

Biotechnology is broadly defined as the application of principles of molecular and cell science to the production of biologically important or industrially useful products. Topics in biotechnology include genetic engineering, pharmaceutical development, and bio-manufacturing.

In order to be eligible for entrance to the Biotechnology major, a student must have:

For the Bachelor of Science degree in Biotechnology, a minimum of 125 credits is required:

15 of the 45 credits for General Education are included in the Requirements for the Major.This includes: 9 credits of GN courses; 6 credits of GQ courses.

Connecting career and curiosity, the General Education curriculum provides the opportunity for students to acquire transferable skills necessary to be successful in the future and to thrive while living in interconnected contexts. General Education aids students in developing intellectual curiosity, a strengthened ability to think, and a deeper sense of aesthetic appreciation. These are requirements for all baccalaureate students and are often partially incorporated into the requirements of a program. For additional information, see the General Education Requirements section of the Bulletin and consult your academic adviser.

The keystone symbol appears next to the title of any course that is designated as a General Education course. Program requirements may also satisfy General Education requirements and vary for each program.

All students enrolled in a college or the Division of Undergraduate Studies at University Park, and the World Campus are required to take 1 to 3 credits of the First-Year Seminar, as specified by their college First-Year Engagement Plan.

Other Penn State colleges and campuses may require the First-Year Seminar; colleges and campuses that do not require a First-Year Seminar provide students with a first-year engagement experience.

First-year baccalaureate students entering Penn State should consult their academic adviser for these requirements.

6 credits are required and may satisfy other requirements

3 credits required from the college of graduation and likely prescribed as part of major requirements.

A minimum of 120 degree credits must be earned for a baccalaureate degree. The requirements for some programs may exceed 120 credits. Students should consult with their college or department adviser for information on specific credit requirements.

Candidates must complete the degree requirements for their major and earn at least a 2.00 grade-point average for all courses completed within their degree program.

The college dean or campus chancellor and program faculty may require up to 24 credits of course work in the major to be taken at the location or in the college or program where the degree is earned. Credit used toward degree programs may need to be earned from a particular source or within time constraints (see Senate Policy 83-80). For more information, check the Suggested Academic Plan for your intended program.

To graduate with a B.S. degree in Biotechnology, a grade of C or better is required in 9 credits of any BIOTC, B M B, or MICRB 400-level course except BMB442, BMB443W, BMB445W, BMB448, BMB488, BMB496, MICRB421W, MICRB422, MICRB447.

To graduate, a student enrolled in the major must earn a grade of C or better in each course designated by the major as a C-required course, as specified by Senate Policy 82-44.

This option provides both the academic and clinical preparation for students interested in a career as a clinical laboratory scientist. Positions are found in hospital, physician-office, reference, industrial, and research laboratories. To complete baccalaureate degree requirements, students enter a ten-month clinical practicum (MICRB405A, MICRB405B, MICRB405C, MICRB405D, MICRB405E, MICRB405F) at an affiliate hospital for the senior year. (Current affiliations are with Mount Nittany Medical Center, State College and Pennsylvania Hospital, Philadelphia.) Students are recommended for a fixed number of hospital positions on a competitive basis. Cumulative grade-point average and hospital school admission requirements serve as criteria for recommendation. The B.S. degree is awarded at the first commencement following completion of the clinical practicum.

PROFESSOR Loida Escote-Carlson, in charge

The integrated B.S. in Biotechnology-Master of Biotechnology degree program is designed to enable qualified undergraduate students in the B.S. Biotechnology program to graduate in five years with the Master of Biotechnology degree. The requirements of the Master of Biotechnology degree are designed to prepare students for diverse career opportunities in the burgeoning biotechnology industry. The integrated B.S. Biotechnology-Master of Biotechnology program will enhance the preparation and qualifications of B.S. Biotechnology students seeking entry-level positions in biotechnology and related industries. At the same time, students develop a practical knowledge of the laboratory techniques that underlie current research in the life sciences that will serve as excellent preparation for those students in the Master of Biotechnology program who later decide to pursue further graduate degrees.

A maximum of 12 credits will be cross-counted towards the B.S. and Masters degrees, from the following courses:

Total credits required: 125GENERAL EDUCATION: 46 credits (15 of these are included in the REQUIREMENTS FOR THE MAJOR)REQUIREMENTS FOR THE MAJOR: 94-95 creditsPrescribed courses: 67 creditsAdditional courses: 6-9 creditsSupporting courses and related areas: 18-21 credits

Total credits required: 30 (18 of which must be from 500-level courses)Required courses: 16-19 creditsElectives: 11-14 credits

The objectives of the universitys academic advising program are to help advisees identify and achieve their academic goals, to promote their intellectual discovery, and to encourage students to take advantage of both in-and out-of class educational opportunities in order that they become self-directed learners and decision makers.

Both advisers and advisees share responsibility for making the advising relationship succeed. By encouraging their advisees to become engaged in their education, to meet their educational goals, and to develop the habit of learning, advisers assume a significant educational role. The advisees unit of enrollment will provide each advisee with a primary academic adviser, the information needed to plan the chosen program of study, and referrals to other specialized resources.

READ SENATE POLICY 32-00: ADVISING POLICY

Jennifer KeeferAcademic Adviser239 Ritenour BuildingUniversity Park, PA 16802814-863-5487jls227@psu.edu

The suggested academic plan(s) listed on this page are the plan(s) that are in effect during the 2020-21 academic year. To access previous years' suggested academic plans, please visit the archive to view the appropriate Undergraduate Bulletin edition (Note: the archive only contain suggested academic plans beginning with the 2018-19 edition of the Undergraduate Bulletin).

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

All incoming Schreyer Honors College first-year students at University Park will take ENGL/CAS 137 in the fall semester and ENGL/CAS 138 in the spring semester. These courses carry the GWS designation and replace both ENGL 30 and CAS 100. Each course is 3 credits.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

The course series listed below provides only one of the many possible ways to move through this curriculum. The University may make changes in policies, procedures, educational offerings, and requirements at any time. This plan should be used in conjunction with your degree audit (accessible in LionPATH as either an Academic Requirements or What If report). Please consult with a Penn State academic adviser on a regular basis to develop and refine an academic plan that is appropriate for you.

University Requirements and General Education Notes:

US and IL are abbreviations used to designate courses that satisfy University Requirements (United States and International Cultures).

W, M, X, and Y are the suffixes at the end of a course number used to designate courses that satisfy University Writing Across the Curriculum requirement.

GWS, GQ, GHW, GN, GA, GH, and GS are abbreviations used to identify General Education program courses. General Education includes Foundations (GWS and GQ) and Knowledge Domains (GHW, GN, GA, GH, GS, and Integrative Studies). Foundations courses (GWS and GQ) require a grade of C or better.

Integrative Studies courses are required for the General Education program. N is the suffix at the end of a course number used to designate an Inter-Domain course and Z is the suffix at the end of a course number used to designate a Linked course.

This major has two options: Clinical Laboratory Option or General Option. Graduates from the General option frequently accept positions in the bio-pharmaceutical industry or with newly-emerging biotechnology companies bringing new products to market. Graduates from the Clinical Lab Science Option are prepared to complete the certification exam necessary to work as a Medical Laboratory Scientist in a hospital or other medical laboratory.

A BS in Biotechnology prepares students for a wide variety of careers, including industry, health related professions, and careers in academic or government labs. Examples of biotechnology related careers are:

Many students with a BS in Biotechnology will pursue graduate education in biotechnology, management, policy or other related disciplines. Penn State students interested in pursuing a MS in Biotechnology can enroll in the integrated undergraduate graduate (IUG) program. IUG students complete a BS and MS with 5 years of coursework, which includes a nine-month internship in industry, government or academia. A BS in Biotechnology also prepares students to pursue higher degrees in the health professions. Opportunities for graduate studies include, but are not limited to, the following:

MORE INFORMATION ABOUT OPPORTUNITIES FOR GRADUATE STUDIES

The rest is here:
Biotechnology, B.S. & Penn State

Read More...

Page 25«..1020..24252627..3040..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick